139 related articles for article (PubMed ID: 18411458)
1. FDA notifications. FDA provides more info in response to Viracept recall.
AIDS Alert; 2007 Nov; 22(11):129-31. PubMed ID: 18411458
[No Abstract] [Full Text] [Related]
2. FDA notifications. New dosing option approved for Viracept.
AIDS Alert; 2003 Jul; 18(7):90. PubMed ID: 12846198
[No Abstract] [Full Text] [Related]
3. Nelfinavir (Viracept) approved: fourth protease inhibitor available.
James JS
AIDS Treat News; 1997 Mar; (No 267):1-2. PubMed ID: 11364249
[TBL] [Abstract][Full Text] [Related]
4. Nelfinavir: fourth protease inhibitor approved.
Crit Path AIDS Proj; 1997; (No 32):31-2. PubMed ID: 11364442
[TBL] [Abstract][Full Text] [Related]
5. Fourth protease inhibitor hits the market.
AIDS Alert; 1997 May; 12(5):59-60. PubMed ID: 11364224
[TBL] [Abstract][Full Text] [Related]
6. FDA notifications. FDA grants approval for raltegravir.
AIDS Alert; 2009 Apr; 24(4):46-8. PubMed ID: 19382366
[No Abstract] [Full Text] [Related]
7. EMS in Viracept--the course of events in 2007 and 2008 from the non-clinical safety point of view.
Müller L; Singer T
Toxicol Lett; 2009 Nov; 190(3):243-7. PubMed ID: 19857794
[TBL] [Abstract][Full Text] [Related]
8. What happened: the chemistry side of the incident with EMS contamination in Viracept tablets.
Gerber C; Toelle HG
Toxicol Lett; 2009 Nov; 190(3):248-53. PubMed ID: 19857795
[TBL] [Abstract][Full Text] [Related]
9. FDA notifications. FDA approves half-strength Kaletra.
AIDS Alert; 2008 Jan; 23(1):10. PubMed ID: 18572474
[No Abstract] [Full Text] [Related]
10. FDA notifications. Agenerase product label changed.
AIDS Alert; 2002 Oct; 17(10):131. PubMed ID: 12400469
[No Abstract] [Full Text] [Related]
11. FDA notifications. FDA tentatively approves generic atazanavir.
AIDS Alert; 2008 Mar; 23(3):32. PubMed ID: 18661639
[No Abstract] [Full Text] [Related]
12. FDA notifications. UCB Pharma and FDA issue advisory letter.
AIDS Alert; 2004 Feb; 19(2):22-4. PubMed ID: 15011629
[No Abstract] [Full Text] [Related]
13. FDA notifications. Generic lopinavir/ritonavir approved by FDA.
AIDS Alert; 2009 May; 24(5):59. PubMed ID: 19452652
[No Abstract] [Full Text] [Related]
14. FDA notifications. FDA approves NDA for Lexiva.
AIDS Alert; 2007 Dec; 22(12):142. PubMed ID: 18415960
[No Abstract] [Full Text] [Related]
15. FDA notifications. Fosamprenavir label is updated.
AIDS Alert; 2008 Feb; 23(2):21-2. PubMed ID: 18578033
[No Abstract] [Full Text] [Related]
16. FDA asks LyphoMed to recall intravenous solution.
Wagner M
Mod Healthc; 1988 Jul; 18(31):5. PubMed ID: 10288204
[No Abstract] [Full Text] [Related]
17. FDA notifications. Revised atazanavir package insert.
AIDS Alert; 2008 Mar; 23(3):35-6. PubMed ID: 18661642
[No Abstract] [Full Text] [Related]
18. The Viracept (nelfinavir)--ethyl methanesulfonate case: a threshold risk assessment for human exposure to a genotoxic drug contamination?
Lutz WK
Toxicol Lett; 2009 Nov; 190(3):239-42. PubMed ID: 19695319
[TBL] [Abstract][Full Text] [Related]
19. FDA notifications. Updates made to Reyataz package insert.
AIDS Alert; 2008 Oct; 23(10):116-7. PubMed ID: 18935687
[No Abstract] [Full Text] [Related]
20. FDA notifications. Alternative dosing regimen for atazanavir is approved.
AIDS Alert; 2008 Nov; 23(11):129-30. PubMed ID: 19048649
[No Abstract] [Full Text] [Related]
[Next] [New Search]
